🇺🇸 FDA
Patent

US 7759361

Azabicyclooctan-3-one derivatives and use thereof

granted A61KA61K31/439A61P

Quick answer

US patent 7759361 (Azabicyclooctan-3-one derivatives and use thereof) held by APREA AB expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
APREA AB
Grant date
Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K31/439, A61P, A61P35/00, A61P37/06